The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(4-(((S)-3-((dimethylamino)methyl)pyrrolidin-1-yl)methyl)-3-(trifluoromethyl)phenyl)(4-methyl-3-(4-(pyrimidin-5-yl)pyrimidin-2-ylamino)phenylamino)methanol hydrochloride ID: ALA538337
PubChem CID: 45265933
Max Phase: Preclinical
Molecular Formula: C31H36ClF3N8O
Molecular Weight: 592.67
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(NC(O)c2ccc(CN3CC[C@@H](CN(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1.Cl
Standard InChI: InChI=1S/C31H35F3N8O.ClH/c1-20-4-7-25(13-28(20)40-30-37-10-8-27(39-30)24-14-35-19-36-15-24)38-29(43)22-5-6-23(26(12-22)31(32,33)34)18-42-11-9-21(17-42)16-41(2)3;/h4-8,10,12-15,19,21,29,38,43H,9,11,16-18H2,1-3H3,(H,37,39,40);1H/t21-,29?;/m0./s1
Standard InChI Key: WUBCUCUJJCTKCP-HUZAIJNCSA-N
Molfile:
RDKit 2D
44 47 0 0 0 0 0 0 0 0999 V2000
9.7625 -6.1583 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1.6528 -4.5250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6516 -5.3524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3664 -5.7652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0829 -5.3519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0800 -4.5214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3646 -4.1122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7980 -5.7633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7993 -6.5883 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.5118 -5.3496 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5105 -4.5246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2245 -4.1166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2235 -3.2924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5079 -2.8802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7917 -3.2983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7961 -4.1211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5055 -2.0552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9376 -2.8791 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6525 -3.2909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6481 -4.1136 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.3622 -4.5253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0772 -4.1119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0737 -3.2827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3590 -2.8748 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.7862 -2.8669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5027 -3.2778 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2147 -2.8627 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.2114 -2.0368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4900 -1.6278 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.7809 -2.0453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9382 -4.1127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2238 -4.5253 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.3622 -3.2872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3542 -2.4584 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.1871 -3.2820 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.5372 -3.2963 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-0.5270 -4.1916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0789 -4.8048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6662 -5.5193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1406 -5.3474 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8994 -4.7188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2352 -3.9652 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.0557 -3.8792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7504 -3.2976 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21 22 2 0
3 4 1 0
22 23 1 0
11 12 2 0
23 24 2 0
24 19 1 0
6 7 2 0
23 25 1 0
12 13 1 0
25 26 2 0
7 2 1 0
26 27 1 0
13 14 2 0
27 28 2 0
2 3 2 0
28 29 1 0
14 15 1 0
29 30 2 0
30 25 1 0
5 8 1 0
2 31 1 0
15 16 2 0
31 32 1 0
16 11 1 0
7 33 1 0
4 5 2 0
33 34 1 0
14 17 1 0
33 35 1 0
8 9 1 0
33 36 1 0
32 37 1 0
13 18 1 0
18 19 1 0
8 10 1 0
37 38 1 0
38 39 1 0
39 40 1 0
40 32 1 0
19 20 2 0
38 41 1 1
5 6 1 0
41 42 1 0
20 21 1 0
42 43 1 0
10 11 1 0
42 44 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 592.67Molecular Weight (Monoisotopic): 592.2886AlogP: 5.49#Rotatable Bonds: 10Polar Surface Area: 102.33Molecular Species: BASEHBA: 9HBD: 3#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: 12.58CX Basic pKa: 9.61CX LogP: 4.53CX LogD: 2.29Aromatic Rings: 4Heavy Atoms: 43QED Weighted: 0.21Np Likeness Score: -1.53
References 1. Horio T, Hamasaki T, Inoue T, Wakayama T, Itou S, Naito H, Asaki T, Hayase H, Niwa T.. (2007) Structural factors contributing to the Abl/Lyn dual inhibitory activity of 3-substituted benzamide derivatives., 17 (10): [PMID:17376680 ] [10.1016/j.bmcl.2007.03.002 ]